W STRATEGIES, LLC

Lobbying for GILEAD SCIENCES, INC. · American biotechnology company that researches, develops and commercializes drugs.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · $60,000.00 income · posted Apr 20, 2026

Bills named in this filing 1

Lobbying activity 1

Medicare/Medicaid

Implementation H.R.5376 - Inflation Reduction Act of 2022. Public Law 119-21: One Big Beautiful Bill Act. Issues around drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.